OBJECTIVE: To compare the efficacy and safety of memantine vs placebo in patients with moderate to severe AD already receiving stable treatment with donepezil. DESIGN, SETTING, AND PARTICIPANTS ...

Consequently, combination therapy currently involves the administration of one cholinergic drug (donepezil, galantamine or rivastigmine) and one glutamatergic drug (memantine). There have been no ...

There are four medications approved in the UK to ease a person’s dementia symptoms, including memory and thinking problems: donepezil rivastigmine galantamine memantine. These treatments are only ...

Nystagmus is characterized by involuntary to and fro movement of the eyes. There is evidence to indicate that memantine and gabapentin can reduce acquired nystagmus, but these drugs have not been ...

Donepezil (Aricept) was approved in 1996, Rivastigmine (Exelon) was approved in 2000, and galantamine (Reminyl) was approved in 2001. In October, 2003, the FDA approved Memantine (Namenda) for the ...

However, given the upcoming patent expirations (rivastigmine going off-patent in 2007, galantamine in 2008, donepezil and memantine in 2010) and the likely entry of generics, the total value of ...

治疗通常包括： 药物治疗： 胆碱酯酶抑制剂：如多奈哌齐（Donepezil），用于改善认知功能。 NMDA受体拮抗剂：如美金刚（Memantine），用于改善中至 ...

The new study was conducted to explore whether combining two existing drugs, Donepezil and Memantine, could offer a more effective treatment approach. Previous research had suggested that these ...

Anavex announced new data from their phase 2b/3 Alzheimer's trial, which was presented at the CTAD 2024 conference. Read why ...

And do not stop taking Aricept unless your doctor recommends it. Aricept may cause mild side effects other than those listed above. See the drug’s prescribing information for details.

Aricept (donepezil) is a brand-name drug prescribed for dementia related to Alzheimer’s disease. Aricept has interactions with other drugs and certain supplements. Examples include ...